Mastering GLP-1 Compounding Webinar Series Part 1: Understanding FDA Regulations: Key Insights for 503A and 503B Compounding

Frier Levitt attorneys Martha Rumore, Dae Lee, and Lucas Morgan presented part 1 of our “Mastering GLP-1 Compounding: Regulatory Insights, Business Strategies, Reimbursement, Telehealth, and Legal Considerations,” a 3-part webinar series designed for pharmacy professionals, including pharmacy owners, pharmacists, and pharmacy technicians. This series offers an in-depth exploration of the current regulatory landscape for compounding pharmacies.

In Part 1, “Understanding FDA Regulations: Key Insights for 503A and 503B Compounding,” Martha, Dae, and Lucas covered:

  • Current Regulatory Environment for 503A and 503B Compounding
  • State Laws and State Board of Pharmacy 2023/2024
  • Important Regulatory Considerations in the 503B to 503A Compounding
  • Model for Community Pharmacies
  • 506e Shortages and Beyond
  • USP 797/795 Six Months Later

Share: